📊 Score Breakdown
Offering Ability
90
Cash Runway
95
Float Risk
50
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
52%
💰 Capital Raise
75%
• Critical: only 2.6 months cash remaining
• Active shelf registration ($100M, 767% of market cap)
📜 Warrant Exercise
40%
• Significant warrants: 26% of shares outstanding
• Elevated warrant risk score (70/100)
🔄 Reverse Split
15%
• Only 3 months cash — financial pressure
💹 Market Data
Market Cap$13.04M
Shares Outstanding8.00M
Float4.83M
Cash$890.6K
Debt$324.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 82.6% shares (2025Q4 vs prior)
4 institutional holders · 2.04M shares
#1
Glenview Trust Co
1.99M shares
#2
BANK OF AMERICA CORP /DE/
36.6K shares
#3
FNY Investment Advisers, LLC
14.7K shares
+ 1 more holders Sign up free to view →
📉 Short Interest
Short Interest96.9K
Days to Cover1.1
% of Float2.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
EFFECT
EFFECT
May 01, 2026
S-3
SHELF
Apr 17, 2026
4
INSIDER TRANSACTION
Apr 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BNKK
📊 BNKK FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BNKK Signal Convergence & Dark Pool Activity — StonkWhisper
📄 BNKK Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.